Visual assessment of brain FDG PET data represents a fundamental skill, independent of the particular clinical indication toward which it is being applied. In our imaging facility, we routinely employ a systematic approach for evaluating regional metabolism throughout the brain. In addition, beginning in 2004, software tools approved by the Food and Drug Administration for quantifying relative regional activity became available to assist with that evaluation. This chapter first describes key aspects of a skilled visual assessment, and then examines methods of regional quantification that are practical in typical clinical environments, and, finally, illustrates an approach toward scan interpretation that integrates the visual and quantifying information present in clinical PET scans.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
1. Buchert R, Santer R, Brenner W, et al. Computer simulations suggest that acute correction of hyperglycemia with an insulin bolus protocol might be useful in brain FDG PET. Nuklearmedizin 2009:(in press).
2. Minoshima S, Frey KA, Burdette JH, Interpretation of metabolic abnormalities in Alzheimer’s disease using three-dimensional stereotactic surface projections (3D-SSP) and normal database. J Nucl Med 1995;36:237P.
3. Moeller JR, Ishikawa T, Dhawan V. The metabolic topography of normal aging. J Cereb Blood Flow Metab 1996;16:385–398.
4. Ishii K, Sakamoto S, Sasaki M. Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med 1998;39:1875–1878.
5. Silverman DHS, Alavi A. PET imaging in the assessment of normal and impaired cognitive function. Radiol Clin North Am 2005;43:67–77.
6. Minoshima S, Giordani B, Berent S. Metabolic reduction in the posterior cingulate cortex in very early AD. Ann Neurol 1997;42:85–94.
7. Silverman DHS. Brain F-18-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging. J Nucl Med 2004;45:594–607.
Silverman DHS, Small GW, Chang CY et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and longterm outcome. JAMA 2001;286:2120–2127.
Silverman DH, Truong CT, Kim SK, et al. Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET. Mol Genet Metab 2003;80:350–355.
Silverman DH, Mosconi L, Ercoli L, et al. Positron emission tomography scans obtained for the evaluation of cognitive dysfunction. Semin Nucl Med 2008;38:251–61.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science + Business Media, LLC
About this chapter
Cite this chapter
Silverman, D.H. (2009). Clinical Interpretation of Brain PET Scans: Performing Visual Assessments, Providing Quantifying Data, and Generating Integrated Reports. In: Silverman, D. (eds) PET in the Evaluation of Alzheimer's Disease and Related Disorders. Springer, New York, NY. https://doi.org/10.1007/978-0-387-76420-7_2
Download citation
DOI: https://doi.org/10.1007/978-0-387-76420-7_2
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-76419-1
Online ISBN: 978-0-387-76420-7
eBook Packages: MedicineMedicine (R0)